Consultation to amend List A (List of certain antimicrobial active pharmaceutical ingredients) - Proposed List A 2022

From Health Canada

Current status: Open

Opened on March 07, 2022 and will close to new input on June 06, 2022

We would like your comments on a proposal to amend List A which names certain antimicrobial active pharmaceutical ingredients that are important in human medicine. Ingredients on List A are subject to measures to help limit the development of resistance to these medically important antimicrobials and these measures are part of Health Canada's commitment to protect public health and food safety.

At Health Canada's Veterinary Drugs Directorate (VDD), we make changes to List A as required, including when:

Since publication of List A in 2017, newer antimicrobial agents that are important to human medicine have become available. Health Canada has conducted a literature-based examination of antimicrobial drugs against a set of established criteria available on the Health Canada's website and identified additional antimicrobial agents to be considered for inclusion or reclassification on List A.

To comply with Canada's international trade obligations, consultation on the proposed List A is also being conducted by notifying the World Trade Organization.

Join in: how to participate

Who is the focus of this consultation

Health Canada's VDD will engage with:

Goals of the consultation

The goal of the consultation is to get your comments on the Proposed List A 2022. After the consultation, we will consider and address any comments received before we finalize the List A with the effective implementation date.

Key question for consultation

We are seeking your input on the proposed amendments to List A 2022.

Related information

Contact us

Veterinary Drugs Directorate
Human Safety Division
Health Products and Foods Branch, Health Canada
E-mail: vdd.HSD-DIH.dmv@hc-sc.gc.ca

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: